Menu
Enrolling by invitation NCT04565704

Optical Imaging of Gastrointestinal Biopsy Samples and Their Correlation With Histology

No phase Interventional Gastrointestinal Disease Gastrointestinal Dysfunction

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Biopsy imaged by Optical imaging device..
Who it may be relevant to
Registry conditions: Gastrointestinal Disease, Gastrointestinal Dysfunction. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

To develop novel optical imaging technologies for use as a non-destructive and minimally invasive tool for detection and diagnosis of various diseases that affect the gastrointestinal system.

Detailed description

The investigators have previously developed optical imaging systems that have been able to provide highly detailed images of tissue structures in multiple application areas including Cardiology, Gastroenterology, and Pulmonology. They are looking to continue the advancement of these various technologies under development.

The population will include participants who are undergoing elective esophagogastroduodenoscopy with biopsy, colonoscopy with biopsy, and/or endo-mucosal resection.The endoscopist will take no more than 3 biopsies in addition to the standard of care biopsies.

The study will be optical imaging of the ex vivo GI specimens that are being collected. Specimens will be collected for research purposes only. Offline analysis of the samples will be performed, and optical imaging findings will be correlated with the pathology findings. This will require review of the medical record to link the findings of the imaging with the pertinent medical information. Samples will be de-identified and participants will be assigned a unique number. The tissues will be placed in marked containers labeled "for research purposes only". The samples collected will be brought to the Tearney Research Laboratory for imaging and processing. The Optical imaging of the tissue samples will not affect the standard of care procedure.

Interventions

  • Device Biopsy imaged by Optical imaging device.

Primary outcome measures

  • Device Feasibility based on image quality and presence of microscopic features [Time frame: Imaging data is collected during the procedure, and analyzed within 1 year of collection.]

Eligibility criteria

Inclusion criteria

  • Scheduled for an elective esophagoduodenoscopy and/or colonoscopy

Exclusion criteria

  • According to standard of care at MGH endoscopy department.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Device feasibility

Study locations

United States · 1 center
  • Massachusetts General Hospital — Boston

Identifiers

NCT: NCT04565704 · 2015P000328

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗